-
-
Call more information
660-596-2224 -
Acta Anaesthesiol Scand 2015 Apr 21. Authors: Florkiewicz P et al BACKGROUND: Remifentanil, an ultra-short-acting opioid, provides intensive analgesia without prolonged respiratory depression and is widely used in cardiac surgery. Diminished dosing may also offer stable hemodynamics, even during sternotomy and sternal retraction. However, increased postoperative pain and induced opioid tolerance after remifentanil dosing during abdominal surgery […]
Read MoreAnesthesia & Analgesia: July 2015- Volume 121-Issue 1- p 219-222 Authors: Fahy, Brenda G. MD et al Obtaining anesthesia informed consent for a series of repetitive debridements in burn-injured patients requires a significant time investment for anesthesiologists and patient families. A single consent form was introduced that covered multiple related anesthetics in burn patients. The […]
Read MoreAnesthesia & Analgesia: April 28, 2018 Authors: Dexter, Franklin MD, PhD et al BACKGROUND: We analyze data from the American Society of Anesthesiologist’s (ASA) Anesthesia Quality Institute (AQI) to report the U.S. anesthesia workload by time of day and day of the week. We consider the extent to which first case starts, rather than durations […]
Read MoreThe transition from extensive use of intravenous (IV) sedation for interventional pain procedures to almost exclusive use of oral anxiolysis at an outpatient pain center led to significant improvements in patient satisfaction and recovery times, a new study shows. But not all practitioners are on board with such a policy, citing potential safety issues. “The […]
Read MoreMore than half of Medicare beneficiaries undergoing cataract surgery undergo at least one preoperative test, despite strong evidence showing that preoperative tests are not associated with any improvement in outcomes, new research shows. Moreover, the prevalence of preoperative testing before cataract surgery is not different than it was 20 years ago, before the introduction of […]
Read MoreAnesthesia & Analgesia: April 28, 2015 Authors: Tassonyi, Edömér MD, PhD et al BACKGROUND: Pipecuronium is a steroidal neuromuscular blocking agent. Sugammadex, a relaxant binding [gamma]-cyclodextrin derivative, reverses the effect of rocuronium, vecuronium, and pancuronium. We investigated whether sugammadex reverses moderate pipecuronium-induced neuromuscular blockade (NMB) and the doses required to achieve reversal. METHODS: This single-center, […]
Read MoreAnaesthesist 2015 May;64(5):347-56. doi: 10.1007/s00101-015-0023-9. Authors: Ninke T et al Abstract During the perioperative and postoperative care of pregnant women it is prudent to pay close attention to the changed physiology of these patients. The main principles of care are the preservation of maternal and fetal homeostasis as well as avoidance of any substances with toxic effects […]
Read MoreBMJ 2015 Apr 16;350:h1748. Authors: Cohen SP et al OBJECTIVE: To evaluate whether an epidural steroid injection or gabapentin is a better treatment for lumbosacral radiculopathy. DESIGN: A multicenter randomized study conducted between 2011 and 2014. Computer generated randomization was stratified by site. Patients and evaluating physicians were blinded to treatment outcomes. SETTINGS: Eight military, Veterans Administration, […]
Read MoreA Survey of Anaesthesia Staff BMC Anesthesiol. 2015;15(13) Authors: Johannes Wacker et al Background Underreporting of intraoperative events in anaesthesia is well-known and compromises quality documentation. The reasons for such omissions remain unclear. We conducted a questionnaire-based survey of anaesthesia staff to explore perceived barriers to reliable documentation during anaesthesia. Methods Participants anonymously completed a paper-based questionnaire. Predefined […]
Read MoreA sudden and substantial drop in prescription opioid dispensing matched by a similar decrease in opioid overdose has been noted within 2 years of the introduction of abuse-deterrent extended- release formulations of oxycodone (multiple brands) along with the removal of propoxyphene (multiple brands), a weak opioid, from the prescription market, new research shows. Introduction of […]
Read More